PlantForm Corporation is a Canadian biopharmaceutical company focused on the rapid development and production of specialty biotherapeutics using a plant-based expression system. PlantForm’s expertise in the growth, manipulation, and extraction of materials from plants has allowed the company to develop a portfolio of drugs advancing through development. PlantForm has developed a proprietary plant-based expression system, vivoXPRESS®, which uses the plant Nicotiana benthamiana as the production platform. The plant-based vivoXPRESS® system is a reproducible, faster, and less expensive way to produce biologic drugs for a broad range of indications. The company’s pipeline is focused on two key areas: 1) Biosimilar versions of marketed drugs for cancer and other indications. Biosimilar drugs, like generic small molecule drugs, are copies of innovative drugs which may enter the market on patent expiry of the innovative drug. 2) Medical countermeasures against bioterror threats such as Ricin. The company also conducts partnered work with other organizations. The Company has been awarded grants from pharmaceutical and biotechnology companies as well as Governments and Foundations for co-development of drugs, vaccines, medical devices, and other high value applications.